In the latest episode of the OIS podcast, host Dr. Rob Rothman delves into the transformative...
43:51
From Ophthalmology Clinics to Business Leadership
In this episode, Dr. Jai Parekh shares his journey from ophthalmology to business leadership in...
51:23
Exploring the Future of Eye Care
Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist...
38:31
5 Mistakes to Avoid in Biotech Investor Pitch Decks
Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the...
18:32
Unlocking the Future of Presbyopia Treatment
Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to...
19:32
Revolutionizing Ophthalmic Care
In the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating...
37:41
Insights from Startup Leaders on Commercial Strategy and Funding
This panel discussion on startup commercial strategy explores key elements and insights from...
23:39
Maximizing the Value of Your Board of Directors
OIS Podcast host Carey Powers speaks with Dr. Adrienne Graves and Dr. Barbara Wirostko on...
22:04
Revolutionizing Retina Care Beyond Injections
In this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr....
22:10
Revolutionizing Glaucoma Treatment and Innovation Insights
ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on...
32:51
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal...
42:43
Building an Enterprise Under the Radar
Harrow isn’t a household name (yet), but eye care professionals have trusted its products for...
33:04
Approachable Regenerative Medicine
Endogena Therapeutics has developed a novel approach to regenerative medicine that’s not only...
36:13
The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MD
“You can see and feel a buzz within the company right now,” said Andrew Stewart, President,...
28:08
C-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech Companies
OIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal...
20:34
OIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk...
18:04
At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration...
14:12
Accessing Charitable Resources
Keith Valentine is the first and only visually impaired head of a national sight loss...
37:19
What’s New in Ocular Surface Disease?
Two recent drug approvals changed the game for ocular surface disease: Xdemvy (lotilaner...
22:28
Premium
Plus